A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer

Clinical trial NCT06678269 · RECRUITING

Trial details

NCT number: NCT06678269
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Breast Cancer Stage IV Breast Cancer Breast Cancer Breast Cancer Stage IV Breast Cancer Metastatic HER2-negative Breast Cancer HER2 Negative Breast Carcinoma Hormone-receptor-positive Breast Cancer

Start date: 2024-11-15
Primary completion: 2028-11-30
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.